Chargement en cours...
Trial of Divalproex for Bipolar Disorder
The safety and effectiveness of divalproex sodium (Depakapote®) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadel...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pediatric Neurology Briefs Publishers
2002-10-01
|
| Collection: | Pediatric Neurology Briefs |
| Sujets: | |
| Accès en ligne: | https://www.pediatricneurologybriefs.com/articles/1570 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|